Nick Wilson, Richard Edwards, George Thomson, Andrew Waa, Janet Hoek
In this blog we review the case for the Smokefree Aotearoa 2025 Goal. We find that this is an ideal health goal given the large health gains, impact on reducing health inequalities, and savings in health costs that will follow from achieving it. Arguments against having such a goal are also considered.
Frederieke Sanne van der Deen, Prof Nick Wilson, Dr Christine Cleghorn, Dr Linda Cobiac, Dr Giorgi Kvizhinadze, Dr Nhung Nghiem, Prof Tony Blakely
We have eight more years to go until 2025 – the year of the NZ Government’s Smokefree goal. NZ is not on track to achieve this goal, especially not for Māori. In this blog we discuss the findings of our just published study in Tobacco Control, where we have estimated the future impacts of a range of proposed novel and substantive strategies that may accelerate the reduction in smoking prevalence (ie, ‘tobacco endgame strategies’). We find that some endgame strategies could achieve NZ’s Smokefree goal, deliver large health gains and cost-savings, and could largely reduce the ethnic gap in tobacco-related health inequalities.
Dr Amber Pearson, Frederieke Sanne van der Deen, Dr Cristina Cleghorn, Dr Nhung Nghiem, Prof Tony Blakely, Prof Nick Wilson
We have just published research on the health gains and cost-savings from various legally mandated restrictions on tobacco retail outlets. In this blog, we briefly consider the results and put the findings in a wider context of how New Zealand might reach its Smokefree 2025 goal.
Prof Nick Wilson, Prof Janet Hoek, A/Prof George Thomson, Prof Richard Edwards
The NZ Ministry of Health is currently reviewing public submissions on options that would allow nicotine-containing e-cigarettes to be sold legally in NZ. This consultation raises questions about how the wider uptake of e-cigarette use (known as “vaping”) will be managed. In this blog, we consider arguments about the indoor public settings where vaping should be allowed or prohibited. We conclude that there seems an overall strong rationale for “Smokefree = Vapefree” in all circumstances for the indoor areas covered by current smokefree laws and policies.
Professor Janet Hoek, Professor Karine Gallopel-Morvan, Professor Richard Edwards, Professor Tony Blakely
New Zealand’s Smokefree 2025 goal is now less than ten years away but we are unlikely to achieve this world-leading goal unless the Government introduces innovative new policies that reduce smoking prevalence (1). Existing measures have tackled different facets of tobacco marketing, with plain packaging reducing a potent form of tobacco marketing and excise tax increases making smoking less affordable. However, tobacco products themselves have received less attention. In this blog we outline findings from recent studies examining roll-your-own tobacco use and explore potential policy implications.
Roll-your-own tobacco (RYO) has increased in popularity, largely due to its cost advantages, which have persisted despite efforts to reduce differences in the excise tax on RYO tobacco and tailor made (TM) cigarettes (2). Many New Zealand smokers now use loose tobacco to make RYO cigarettes, which are typically around half to two-thirds the size of TM cigarettes (3,4). RYO use is higher among younger demographics, particularly young adults aged 20-24, where more than 60% smoke RYO, either exclusively (42%) or in conjunction with TM cigarettes (20%) (3). Among 25-45 year olds, RYO use (exclusive and with TM cigarettes) is 57%. RYO use is higher among Māori and NZ Europeans than among Pacific peoples (see figure below); people experiencing greater deprivation are also more likely to use RYO tobacco than smokers who experience less deprivation (3). Furthermore, New Zealand RYO smokers are also more likely than TM cigarette smokers to have co-morbidities such as mental health illnesses, illicit drug addictions, and risky drinking behaviours (5).